2. BLOOD PRODUCT = Any therapeutic substance
prepared from human blood.
WHOLE BLOOD = Unseparated blood collected
into an approved container, containing an
anticoagulant preservative solution.
BLOOD COMPONENTS ARE
A constituent of blood , separated from whole
blood such as
⢠Red cell concentrate/Packed Red blood Cells
â˘Platelet concentrates
â˘Fresh Frozen Plasma
â˘Cryoprecipitate
â˘Granulocyte Transfusion.
3. Whole Blood:
⢠Storage
â up to 35 days
⢠Indications
â Massive Blood Loss/Trauma
â Donor and recipient must be ABO
identical.
Adverse Effects:
â˘It loses 50% of platelets after 6 hrs
â˘Granulocyte lose function by 24 hrs
â˘Circulatory volume overload
ďO negative is the product of choice
for emergency transfusion.
4. THE PACKED RED BLOOD CELLS:
Recommended temperature for
transfusion- 33Ëto 35ËC
DOSE- 10ml/kg will increase Hb conc by
2.5-3g/dl.Maximum volume-15ml/kg.
Administration-
- ABO & Rh compatible
-Infuse over 2-4 hrs.
INDICATIONS:
â˘To increase O2 delivery in anemic
patient
â˘In event of acute blood loss âĽ25-40%
blood volume.
5. PLATELET TRANFUSION:
For prevention and treatment of
hemorrhage in thrombocytopenic states.
Dosage - 1 unit/10 kg body wt,
Adult dose is 4-8 units.
Administration - Preferably ABO
& Rh group specific
6. Storage
â Up to 5 days at 20-24ËC
Should be administered over 30 mins
⢠Indications
â Thrombocytopenia, Plt is 10 â 20,000/mmÂł
â Bleeding and Plt <50,000/mmÂł
â Invasive procedure and Plt <50,000/mmÂł
â 1 unit/10 kg of body weight increases Plt
count by 50,000
â Donor and Recipient must be ABO identical
7. The platelets are separated from the plasma by
centrifugation.
⢠Platelets are supplied either as single donor units
or as a combination of multiple donors known as
random donor platelets.
⢠One unit of platelets will increase the platelet
count by 5 to 10,000/mmÂł.
⢠Platelet viability is optimal at 22° C but storage is
limited to 4-5 days.
⢠Platelets have both the ABO and HLA antigens.
ABO compatibility is ideal but not required.
(incompatibility will shorten the life span of the
platelet)
8. FRESH FROZEN PLASMA
⢠ContentsâCoagulation Factors
⢠Storage
â It can be stored for 1yr at â18ËC
⢠Indications
â Coagulation Factor deficiency, fibrinogen
replacement, DIC, liver disease, massive
transfusion.
â˘ABO compatibility is required,Rh typing is
not necessary.
â FFP must be thawed at 36Ë-38ËC before
administration.
Dose-10 to 15ml/kg over 30 to 120 mins.
9. CRYOPRECIPITATE:
â Precipitate formed/collected when FFP is thawed.
⢠Storage
â After collection,refrozen and stored up to 1 year at
-18ËC.
â˘It contains fibrinogen,Factor VIII,Factor XIII and von
Willebrandâs factor.
⢠Indications
â Fibrinogen deficiency
âVonWillebrands Disease
â Factor VIII or XIII deficiency
â hemophilia (if factor VIII is not available)
⢠Considerations
â ABO compatible preferred (but not limiting)
DOSE- 1 unit/5-10 kg of recipient body wt.
10. GRANULOCYTE TRANSFUSION:
⢠Prepared at the time for immediate
transfusion (no storage available)
⢠Indications â
severe neutropenia associated with
infection that has failed antibiotic therapy.
⢠Complications
â Severe allergic reactions
â Can irradiate granulocytes for GVHD
prevention
11. ADVERSE REACTIONS TO TRANSFUSION
⢠Hemolytic Transfusion Reactions (AHTR)
⢠Febrile Non Hemolytic Reactions (FNHTR)
⢠Allergic Reactions
⢠TRALI(Transfusion related acute lung injury)
⢠Post transfusion Infections
12. Acute Hemolytic Transfusion Reactions
(AHTR)
⢠Occurs when incompatible RBCâs are transfused into
recipient who has pre-formed antibodies (usually ABO
or Rh)
⢠Antibodies activate the complement system, causing
intravascular hemolysis
.
⢠Symptoms occur within minutes of starting the
transfusion
⢠Labelling error is most common problem
⢠Can be fatal
13. Symptoms of AHTR
⢠High fever/chills
⢠Hypotension
⢠Back/abdominal pain
⢠Tachycardia
⢠Hemoglobinuria
⢠Pallor
MANAGEMENT
⢠STOP TRANSFUSION
⢠ABCâs
â˘Run IVF
⢠Monitor and maintain BP
⢠Give diuretic
⢠Send remaining blood back to Blood Bank
14. Febrile Nonhemolytic Transfusion
Reactions (FNHTR)
â˘It is rise in patient temperature >1ËC during or
within 2 hrs of completion of transfusion.
â˘Fever occurs due to pyrogenic cytokines from
recipientâs granulocytes.
MANAGEMENT:
â˘Discontinue transfusion
â˘Administer paracetamol and anti-histamines.
15. Allergic reactions/urticaria
â˘It can range from cutaneous manifestation
to anaphylaxis.
â˘Isolated urticaria is the commonest
reaction.
â˘It is due to reaction of patientâs IgE
antibody to foreign proteins in donor
plasma.
â˘Management:
â˘Mild (i.e hives,itching)-antihistamines to be
given and transfusion is restarted.
â˘Severe anaphylaxis-stop transfusion ABCâs
and give steroids.
16. ď Transfusion related acute lung
injury(TRALI)
It is rare and life threatening complication
with plasma containing components.
Due to presence of HLA specific antibodies in
donor plasma.
Usually occurs 1 to 2 hrs to up to 6 hr after
start of transfusion.
Characterized by-
ď bilateral pulmonary edema
ď Hypoxemia,fever
ď Tachycardia
ď Hypotension
ď cyanosis
17. MANAGEMENT
⢠Supportive care for acute respiratory distress
syndrome including positive pressure
ventilation.
⢠Resolution occurs within 48 hrs.
18. The other adverse effects are:
⢠Transfusion associated circulatory
overload
⢠Metabolic abnormality secondary to
blood transfusion
⢠Dilutional coagulopathies
⢠Post-transfusion infections